Suppr超能文献

嗅觉功能障碍的定量评估能准确检测出无症状的新冠病毒携带者。

Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers.

作者信息

Bhattacharjee Anindya S, Joshi Samir V, Naik Shilpa, Sangle Shashikala, Abraham Nixon M

机构信息

Indian Institute of Science Education and Research (IISER), Pune, Maharashtra, 411008, India.

Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals (BJGMC & SGH), Pune, Maharashtra, 411001, India.

出版信息

EClinicalMedicine. 2020 Nov;28:100575. doi: 10.1016/j.eclinm.2020.100575. Epub 2020 Oct 16.

Abstract

BACKGROUND

COVID-19 threatens the global community because a large fraction of infected people are asymptomatic, yet can effectively transmit SARS-CoV-2. Finding and isolating these silent carriers is a crucial step in confining the spread of the disease. A sudden loss of the sense of smell has been self-reported by COVID-19 patients across different countries, consistent with expression of the molecular factors mediating SARS-CoV-2 uptake into human olfactory epithelial supporting cells. However, precise quantification of olfactory loss in asymptomatic COVID-19 carriers is missing to date.

METHODS

To quantify olfactory functions in asymptomatic COVID-19 patients, we designed an olfactory-action meter that determines detectability indices at different odor concentrations and an olfactory matching accuracy score using monomolecular odors. The optimization of test parameters allowed us to reliably and accurately assess olfactory deficits in a patient within 20 minutes.

FINDINGS

Measurement of detection indices at low concentrations revealed a 50% reduction in asymptomatic COVID-19 carriers. Further, patients with better detection scores showed significantly reduced olfactory matching accuracies compared to normal healthy subjects. Our quantification of olfactory loss, considering all parameters, identified 82% of the asymptomatic SARS-CoV-2 carriers with olfactory deficits. However, on subjective evaluation, only 15% of the patients noticed a compromised ability to smell.

INTERPRETATION

Compromised olfactory fitness can serve as a strong basis for identifying asymptomatic COVID-19 patients. Detailed design specifications and protocols provided here should enable the development of a sensitive, fast, and economical screening strategy that can be administered to large populations to prevent the rapid spread of COVID-19.

FUNDING

This work was supported by the DBT - Wellcome Trust India Alliance intermediate grant (IA/I/14/1/501,306 to N.A.) and UGC NET Fellowship (A.B.). All the funding sources played no roles in the study.

摘要

背景

新型冠状病毒肺炎(COVID-19)威胁着全球社会,因为很大一部分感染者没有症状,但却能有效传播严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。找到并隔离这些无症状携带者是遏制疾病传播的关键一步。不同国家的COVID-19患者均自述突然失去嗅觉,这与介导SARS-CoV-2进入人嗅觉上皮支持细胞的分子因子的表达一致。然而,迄今为止,尚无对无症状COVID-19携带者嗅觉丧失情况的精确量化研究。

方法

为了量化无症状COVID-19患者的嗅觉功能,我们设计了一种嗅觉行为测量仪,该测量仪使用单分子气味来确定不同气味浓度下的可检测指数以及嗅觉匹配准确度得分。测试参数的优化使我们能够在20分钟内可靠且准确地评估患者的嗅觉缺陷。

研究结果

低浓度下可检测指数的测量结果显示,无症状COVID-19携带者的该指数降低了50%。此外,与正常健康受试者相比,可检测得分较高的患者嗅觉匹配准确度显著降低。综合所有参数对嗅觉丧失情况进行量化后,我们发现82%的无症状SARS-CoV-2携带者存在嗅觉缺陷。然而,在主观评估中,只有15%的患者注意到嗅觉能力受损。

解读

嗅觉功能受损可作为识别无症状COVID-19患者的有力依据。本文提供的详细设计规范和方案应能推动开发一种灵敏、快速且经济的筛查策略,该策略可应用于大量人群,以防止COVID-19的快速传播。

资金支持

本研究得到了印度生物技术部 - 惠康信托基金会联盟中级资助(授予N.A.的IA/I/14/1/501,306)以及大学教育资助委员会国家资格考试奖学金(授予A.B.)。所有资金来源均未参与本研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddf8/7700904/b129999c6e95/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验